Viome Signs Agreement to Explore Molecular AI Model in Bhutan
Oct 05, 2026
Biotech
BGM Group Acquires Wonder Dragon to Boost Healthcare Strategy
Apr 21, 2025
BGM Group Ltd has announced the acquisition of Wonder Dragon Global Limited to enhance its healthcare strategy by integrating premium Qingzhuan dark tea resources.
BGM Group Ltd has announced the acquisition of Wonder Dragon Global Limited to strengthen its healthcare strategy, announced in a press release. The deal involves BGM Group acquiring 100% of Wonder Dragon's equity by issuing 38,165,290 Class A ordinary shares at $2 per share, valuing the transaction at RMB550 million. Completion is expected in the second quarter of 2025.
Wonder Dragon holds over 3,000 metric tons of premium Qingzhuan dark tea, known for its medicinal and historical value. This acquisition will allow BGM Group to expand its health product portfolio and market reach. The company plans to leverage its AI-powered decision-making platform to optimize tea production and develop new medicinal tea products, such as ginseng and goji berry Qingzhuan dark tea.
BGM Group, based in Chengdu, China, focuses on integrating AI technology, big data analytics, and biopharmaceutical innovations to modernize traditional industries. This acquisition aligns with their strategy to enhance their 'medicine + tea + health' product ecosystem.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 31 Anthropic IPO Filing Details Nearly $900 Billion in Future Obligations Oct 31 Baseten Set to Raise Funding at Up to $30 Billion Valuation, Bloomberg Reports Oct 31 Talky Labs Raises €1.5 Million for AI Accounting Platform Oct 31 Ares Intelligence Raises €2.9 Million for AI Adoption Planning Oct 31 Pixel Systems Raises €2.7 Million for AI Content DetectionMore from Life Sciences
Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology Researchers Oct 30 Surveys Find Widespread AI Chatbot Use Among Teens and Tweens Oct 30 Widow Sues OpenAI and Luka Over Husband's SuicideFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
IBS Agrees to Acquire AI Chip Company for HK$563 Million
Oct 31, 2026
Chips
Ping An Good Doctor Profit Rises 35% as AI Doctor Users Near 13 Million
Oct 23, 2026
Healthcare
DeepSeek Reportedly Agrees to Lead Winverse AI Seed Round
Oct 13, 2026
Funding
Genie Health Raises $3 Million for AI Health Platform
Oct 21, 2026
Funding
Tencent Brings WorkBuddy to Global Sources Hong Kong Show
Oct 18, 2026
AI Events
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.